Associations - etoposide IV

No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	etoposide IV Sensitive: A1 - Approval etoposide IV Sensitive : A1	etoposide IV Sensitive: A1 - Approval etoposide IV Sensitive : A1
No biomarker	Thymoma	No biomarker	Thymoma	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2
No biomarker	Ovarian Cancer	No biomarker	Ovarian Cancer	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2
No biomarker	Neuroendocrine Tumor	No biomarker	Neuroendocrine Tumor	carboplatin + etoposide IV Sensitive: A2 - Guideline carboplatin + etoposide IV Sensitive : A2	carboplatin + etoposide IV Sensitive: A2 - Guideline carboplatin + etoposide IV Sensitive : A2
No biomarker	Germ Cell Tumors	No biomarker	Germ Cell Tumors	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2
No biomarker	Peripheral T-cell Lymphoma	No biomarker	Peripheral T-cell Lymphoma	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2
No biomarker	Peripheral T-cell Lymphoma	No biomarker	Peripheral T-cell Lymphoma	cyclophosphamide + etoposide IV Sensitive: A2 - Guideline cyclophosphamide + etoposide IV Sensitive : A2	cyclophosphamide + etoposide IV Sensitive: A2 - Guideline cyclophosphamide + etoposide IV Sensitive : A2
No biomarker	Bladder Cancer	No biomarker	Bladder Cancer	carboplatin + etoposide IV Sensitive: A2 - Guideline carboplatin + etoposide IV Sensitive : A2	carboplatin + etoposide IV Sensitive: A2 - Guideline carboplatin + etoposide IV Sensitive : A2
No biomarker	Bladder Cancer	No biomarker	Bladder Cancer	cisplatin + doxorubicin hydrochloride + ifosfamide + etoposide IV Sensitive: A2 - Guideline cisplatin + doxorubicin hydrochloride + ifosfamide + etoposide IV Sensitive : A2	cisplatin + doxorubicin hydrochloride + ifosfamide + etoposide IV Sensitive: A2 - Guideline cisplatin + doxorubicin hydrochloride + ifosfamide + etoposide IV Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	cyclophosphamide + ifosfamide + etoposide IV + topotecan Sensitive: A2 - Guideline cyclophosphamide + ifosfamide + etoposide IV + topotecan Sensitive : A2	cyclophosphamide + ifosfamide + etoposide IV + topotecan Sensitive: A2 - Guideline cyclophosphamide + ifosfamide + etoposide IV + topotecan Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	doxorubicin hydrochloride + cyclophosphamide + etoposide IV + vincristine Sensitive: A2 - Guideline doxorubicin hydrochloride + cyclophosphamide + etoposide IV + vincristine Sensitive : A2	doxorubicin hydrochloride + cyclophosphamide + etoposide IV + vincristine Sensitive: A2 - Guideline doxorubicin hydrochloride + cyclophosphamide + etoposide IV + vincristine Sensitive : A2
No biomarker	Osteosarcoma	No biomarker	Osteosarcoma	carboplatin + cyclophosphamide + etoposide IV Sensitive: A2 - Guideline carboplatin + cyclophosphamide + etoposide IV Sensitive : A2	carboplatin + cyclophosphamide + etoposide IV Sensitive: A2 - Guideline carboplatin + cyclophosphamide + etoposide IV Sensitive : A2
No biomarker	Osteosarcoma	No biomarker	Osteosarcoma	cyclophosphamide + etoposide IV Sensitive: A2 - Guideline cyclophosphamide + etoposide IV Sensitive : A2	cyclophosphamide + etoposide IV Sensitive: A2 - Guideline cyclophosphamide + etoposide IV Sensitive : A2
No biomarker	Osteosarcoma	No biomarker	Osteosarcoma	carboplatin + ifosfamide + etoposide IV Sensitive: A2 - Guideline carboplatin + ifosfamide + etoposide IV Sensitive : A2	carboplatin + ifosfamide + etoposide IV Sensitive: A2 - Guideline carboplatin + ifosfamide + etoposide IV Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	carboplatin + ifosfamide + etoposide IV Sensitive: A2 - Guideline carboplatin + ifosfamide + etoposide IV Sensitive : A2	carboplatin + ifosfamide + etoposide IV Sensitive: A2 - Guideline carboplatin + ifosfamide + etoposide IV Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + etoposide IV + mitoxantrone Sensitive: A2 - Guideline cytarabine + etoposide IV + mitoxantrone Sensitive : A2	cytarabine + etoposide IV + mitoxantrone Sensitive: A2 - Guideline cytarabine + etoposide IV + mitoxantrone Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + etoposide IV Sensitive: A2 - Guideline cytarabine + etoposide IV Sensitive : A2	cytarabine + etoposide IV Sensitive: A2 - Guideline cytarabine + etoposide IV Sensitive : A2
No biomarker	Small Cell Lung Cancer	No biomarker	Small Cell Lung Cancer	carboplatin + etoposide IV Sensitive: A2 - Guideline carboplatin + etoposide IV Sensitive : A2	carboplatin + etoposide IV Sensitive: A2 - Guideline carboplatin + etoposide IV Sensitive : A2
No biomarker	Small Cell Lung Cancer	No biomarker	Small Cell Lung Cancer	cisplatin + etoposide IV Sensitive: A2 - Guideline cisplatin + etoposide IV Sensitive : A2	cisplatin + etoposide IV Sensitive: A2 - Guideline cisplatin + etoposide IV Sensitive : A2
No biomarker	Adrenal Cortex Carcinoma	No biomarker	Adrenal Cortex Carcinoma	cisplatin + etoposide IV Sensitive: A2 - Guideline cisplatin + etoposide IV Sensitive : A2	cisplatin + etoposide IV Sensitive: A2 - Guideline cisplatin + etoposide IV Sensitive : A2
No biomarker	Adrenal Cortex Carcinoma	No biomarker	Adrenal Cortex Carcinoma	cisplatin + doxorubicin hydrochloride + etoposide IV + mitotane Sensitive: A2 - Guideline cisplatin + doxorubicin hydrochloride + etoposide IV + mitotane Sensitive : A2	cisplatin + doxorubicin hydrochloride + etoposide IV + mitotane Sensitive: A2 - Guideline cisplatin + doxorubicin hydrochloride + etoposide IV + mitotane Sensitive : A2
No biomarker	Adrenal Cortex Carcinoma	No biomarker	Adrenal Cortex Carcinoma	carboplatin + etoposide IV + mitotane Sensitive: A2 - Guideline carboplatin + etoposide IV + mitotane Sensitive : A2	carboplatin + etoposide IV + mitotane Sensitive: A2 - Guideline carboplatin + etoposide IV + mitotane Sensitive : A2
No biomarker	Adrenal Cortex Carcinoma	No biomarker	Adrenal Cortex Carcinoma	carboplatin + doxorubicin hydrochloride + etoposide IV Sensitive: A2 - Guideline carboplatin + doxorubicin hydrochloride + etoposide IV Sensitive : A2	carboplatin + doxorubicin hydrochloride + etoposide IV Sensitive: A2 - Guideline carboplatin + doxorubicin hydrochloride + etoposide IV Sensitive : A2
No biomarker	Adrenal Cortex Carcinoma	No biomarker	Adrenal Cortex Carcinoma	carboplatin + etoposide IV Sensitive: A2 - Guideline carboplatin + etoposide IV Sensitive : A2	carboplatin + etoposide IV Sensitive: A2 - Guideline carboplatin + etoposide IV Sensitive : A2
No biomarker	Adrenal Cortex Carcinoma	No biomarker	Adrenal Cortex Carcinoma	carboplatin + doxorubicin hydrochloride + etoposide IV + mitotane Sensitive: A2 - Guideline carboplatin + doxorubicin hydrochloride + etoposide IV + mitotane Sensitive : A2	carboplatin + doxorubicin hydrochloride + etoposide IV + mitotane Sensitive: A2 - Guideline carboplatin + doxorubicin hydrochloride + etoposide IV + mitotane Sensitive : A2
No biomarker	Adrenal Cortex Carcinoma	No biomarker	Adrenal Cortex Carcinoma	cisplatin + etoposide IV + mitotane Sensitive: A2 - Guideline cisplatin + etoposide IV + mitotane Sensitive : A2	cisplatin + etoposide IV + mitotane Sensitive: A2 - Guideline cisplatin + etoposide IV + mitotane Sensitive : A2
No biomarker	Adrenal Cortex Carcinoma	No biomarker	Adrenal Cortex Carcinoma	cisplatin + doxorubicin hydrochloride + etoposide IV Sensitive: A2 - Guideline cisplatin + doxorubicin hydrochloride + etoposide IV Sensitive : A2	cisplatin + doxorubicin hydrochloride + etoposide IV Sensitive: A2 - Guideline cisplatin + doxorubicin hydrochloride + etoposide IV Sensitive : A2
No biomarker	Neuroendocrine Tumor	No biomarker	Neuroendocrine Tumor	cisplatin + etoposide IV Sensitive: A2 - Guideline cisplatin + etoposide IV Sensitive : A2	cisplatin + etoposide IV Sensitive: A2 - Guideline cisplatin + etoposide IV Sensitive : A2
No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	carboplatin + etoposide IV Sensitive: A2 - Guideline carboplatin + etoposide IV Sensitive : A2	carboplatin + etoposide IV Sensitive: A2 - Guideline carboplatin + etoposide IV Sensitive : A2
No biomarker	Ependymoma	No biomarker	Ependymoma	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2
No biomarker	Glioma	No biomarker	Glioma	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2

etoposide IV

Associations
(53)

Associations
(53)

etoposide IV

Associations(53)

Associations(53)

Associations
(53)

Associations
(53)